View Exam | PowerPak

1. Which of the following statements is true regarding the size of nanomedicines?

A. Nanomedicines are the same size as bacteria B. Nanomedicines are larger than red blood cells C. Nanomedicines generally range from 1-100 nm D. Nanomedicines are smaller than a single molecule of water E. Unsure

2. Which of the following is a common challenge when developing small molecule pharmaceutical formulation?

A. Bioanalysis of its simple chemical composition B. Rapid dissolution and release in physiological media C. Increase cellular penetration D. Rapid degradation under elevated temperatures E. Unsure

3. Which of the following are approved nanomedicines?

A. Paclitaxel B. Liposomal doxorubicin C. Iron sulfate D. Amphotericin B IV solution E. Unsure

4. Which of the followings is a recognized advantage of nano pharmaceutical formulations?

A. Increased stability of encapsulated molecules B. Rapid oral absorption C. Increased drug interactions with biomolecules D. Increasing dosing frequency E. Unsure

5. Organic nanomedicines include all the following compositions, except _____?

A. Dendrimers B. Liposomes C. Carbon nanotubes D. Quantum dots E. Unsure

6. Nanocrystal nanopharmaceutical products, such as Emend®, Rapamune®, are composed of_________?

A. Assembled phospholipid vesicles B. Metallic gold-core nanoparticles C. Mesoporous silica nanostructures D. Water-insoluble drug substances, without matrix structure E. Unsure

7. Which of the following is an advantage of cationic liposomes for RNA delivery?

A. Improvement in biocompatibility B. Enhancement of dissolution C. Neutralization of anionic charges D. Reduced aggregation and embolism formation E. Unsure

8. Which of the following properties underly the Enhanced Permeability and Retention (EPR) effect?

A. Multi-lamellar and porous composition of nanoparticles B. Direct PEG modification on nanoparticle surface C. Increased volume of distribution D. Controlled release of drug from nanosystem E. Unsure

9. Doxil® in association with Velcade® (Bortezomib), are currently indicated for the treatment of _______?

A. Malignant melanoma B. Recurrent ovarian carcinoma C. AIDS-related Kaposi sarcoma D. Multiple Myeloma E. Unsure

10. The specific manufacturing conditions of an anthracycline nanomedicine product can significantly influence all of the following clinical safety and therapeutic parameters, ECXEPT _________ .

A. Tmax B. AUC0-t C. Apparent T1/2 D. Cmax E. Unsure

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following statements is true regarding the size of nanomedicines?

2. Which of the following is a common challenge when developing small molecule pharmaceutical formulation?

3. Which of the following are approved nanomedicines?

4. Which of the followings is a recognized advantage of nano pharmaceutical formulations?

5. Organic nanomedicines include all the following compositions, except _____?

6. Nanocrystal nanopharmaceutical products, such as Emend®, Rapamune®, are composed of_________?

7. Which of the following is an advantage of cationic liposomes for RNA delivery?

8. Which of the following properties underly the Enhanced Permeability and Retention (EPR) effect?

9. Doxil® in association with Velcade® (Bortezomib), are currently indicated for the treatment of _______?

10. The specific manufacturing conditions of an anthracycline nanomedicine product can significantly influence all of the following clinical safety and therapeutic parameters, ECXEPT _________ .

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following statements is true regarding the size of nanomedicines?

2. Which of the following is a common challenge when developing small molecule pharmaceutical formulation?

3. Which of the following are approved nanomedicines?

4. Which of the followings is a recognized advantage of nano pharmaceutical formulations?

5. Organic nanomedicines include all the following compositions, except _____?

6. Nanocrystal nanopharmaceutical products, such as Emend®, Rapamune®, are composed of_________?

7. Which of the following is an advantage of cationic liposomes for RNA delivery?

8. Which of the following properties underly the Enhanced Permeability and Retention (EPR) effect?

9. Doxil® in association with Velcade® (Bortezomib), are currently indicated for the treatment of _______?

10. The specific manufacturing conditions of an anthracycline nanomedicine product can significantly influence all of the following clinical safety and therapeutic parameters, ECXEPT _________ .

« Return to Activity

Customers who Purchased
this Activity also Purchased